La Maddalena, Italy

Luca Tottone

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Università Degli Studi Di Roma "La Sapienza". Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Luca Tottone

Introduction

Luca Tottone is an accomplished inventor based in La Maddalena, Italy. He has made significant contributions to the field of medical research, particularly in the treatment of T-cell acute lymphoblastic leukemia. His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing healthcare solutions.

Latest Patents

Luca Tottone holds a patent for "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia." This patent involves compounds of formula (I) that demonstrate anti-tumor activity specifically for the treatment of T-cell acute lymphoblastic leukemia (T-ALL). His research in this area is crucial for developing effective therapies for patients suffering from this aggressive form of cancer.

Career Highlights

Throughout his career, Luca has worked with prestigious institutions, including the Università Degli Studi Di Roma "La Sapienza" and the Fondazione Istituto Italiano Di Tecnologia. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Luca has collaborated with notable colleagues, including Isabella Screpanti and Mattia Mori. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Luca Tottone's contributions to the field of medical research, particularly in the treatment of T-cell acute lymphoblastic leukemia, highlight his innovative spirit and commitment to improving patient outcomes. His patent and collaborations reflect his dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…